MISSION

Science
that becomes medicine

VISION

PrimeCell team is working 15 years to discover technologies
to treat unmedical needs of civilisation.

STRATEGY

PrimeCell is the bio-med company focusing on discovering and clinical testing of biological drugs and medicinal technologies, which are changing genes and cells parameters to support regeneration of human tissueas and organs.

We are proud to our results
in regenerative medicine

PATIENTS

SQM OF OUR LABS IN EU

RESEARCH PROJECTS

CORE EMPLOYEES

NEWS

Three years after raising $450M, Andreessen is back with a new $750M life sciences fund

TechCrunch – Life sciences is big business in venture capital land and firms are raising big dollars to find the companies that will lead the next healthcare revolution. Chief among[…]

Read more

Primecell’s immuno-oncology platform uses its proprietary pyroptosis technology to fight cancer

Primecell’s immuno-oncology and immuno-infectious platform uses its proprietary pyroptosis technology to induce tumor cell and pathogen death via immune activation (innate and adaptive) with immune memory surveillance. Primecell has two[…]

Read more

4MEDi – Český vědec opustil Cambridge, aby vedl tým v Ostravě. V buněčné terapii jsou špička

Aktuálně.cz – Vědec Michal Šimíček (34) působil několik let na věhlasném pracovišti v Cambridge, pak se ale vrátil na rodnou severní Moravu. V Ostravě založil centrum, kde zkoumají možnost léčby[…]

Read more

Co-operative transfer research

PrimeCell leads co-operative transfer research with prestigious Universities, Science institutions and technology companies around the world.